Insulin Delivery Devices Market
According to Intent Market Research, the Insulin Delivery Devices Market is expected to grow from USD 29.2 billion in 2023-e at a CAGR of 8.0% to touch USD 50.0 billion by 2030. The insulin delivery devices market is dominated by key players such as Becton & Dickinson, Eli Lilly, Cerur Corporation, Biocon, Wockhardt, Medtronic, Roche, and Owen Mumford.